Journal of Qualitative Research in Health Sciences

Document Type : Original Article

Authors

1 Department of Pharmacy, Faculty of Math and Science, Universitas Udayana, Bali, Indonesia

2 Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta, Indonesia

10.34172/jqr.1504

Abstract

Introduction: Hypoglycemia is a significant challenge in the treatment of diabetic patients, so a deep understanding of this phenomenon is crucial. This study aimed to develop a theoretical framework related to variables that induce hypoglycemia in ambulatory T2DM patients based on their experience, including signs and symptoms that appear and their perception of the hypoglycemia event.
Methods: The participants in this qualitative grounded theory study were ambulatory T2DM patients who were living in Bali Province in 2024. The patients were selected using purposive sampling. The data were collected using individual interviews. The collected data were analyzed using Qualitative Data Analysis (QDA) Miner Lite from Provalis Research.
Results: Patients shared their experiences with severe hypoglycemia. According to them, the factors that induce hypoglycemia were divided into four themes, namely, low nutrient intake, medication-related, lifestyle-related, and comorbid-related hypoglycemia. Patients have an incorrect or partial perception of hypoglycemia events. The phenomenon of patients experiencing hypoglycemia events indicates that they were at risk of experiencing recurrent severe hypoglycemia in the future.
Conclusion: Factors that potentially affected hypoglycemic symptoms were extracted in this study: Ambulatory diabetes medication, inadequate dietary consumption during diabetes management, detrimental lifestyle choices, and diabetes-related comorbidities. Health workers are required to carry out promotive and preventive efforts to prevent hypoglycemia in outpatients.

Keywords

  1. International Diabetes Federation (IDF). IDF Diabetes Atlas. 10th ed. Brussels: IDF; 2021. Available from: https:// diabetesatlas.org/resources/previous-editions/. Accessed November 4, 2024.
  2. World Health Organization (WHO). The Top 10 Causes of Death. Geneva: WHO; 2024. Available from: https://www. who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death. Accessed November 4, 2024.
  3. Pratiwi C, Rumende M, Kshanti IA, Soewondo P. Risk factors for inpatient hypoglycemia in a tertiary care hospital in Indonesia. J ASEAN Fed Endocr Soc 2022;37(2):28-33. doi:10.15605/jafes.037.02.06
  4. Rudijanto A, Saraswati MR, Yunir E, Kumala P, Puteri HH, Mandang VV. Indonesia cohort of IO HAT study to evaluate diabetes management, control, and complications in retrospective and prospective periods among insulin-treated patients with type 1 and type 2 diabetes. Acta Med Indones 2018;50(1):26-37.
  5. American Diabetes Association Professional Practice Committee. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022. Diabetes Care 2022;45(Suppl 1):S17-38. doi:10.2337/dc22-S002
  6. Brown JB, Reichert SM, Valliere Y, Webster-Bogaert S, Ratzki- Leewing A, Ryan BL, et al. Living with hypoglycemia: an exploration of patients’ emotions: qualitative findings from the InHypo-DM Study, Canada. Diabetes Spectr 2019;32(3):270- 6. doi:10.2337/ds18-0074
  7. Mojdami D, Mitchell BD, Spaepen E, Syring K, Rabasa- Lhoret R, Punthakee Z, et al. Conversations and reactions around severe hypoglycemia study: results of hypoglycemia experiences in Canadian adults with insulin-treated diabetes and their caregivers. Can J Diabetes 2021;45(3):236-42. doi:10.1016/j.jcjd.2020.08.104
  8. Nakhleh A, Shehadeh N. Hypoglycemia in diabetes: an update on pathophysiology, treatment, and prevention. World J Diabetes 2021;12(12):2036-49. doi:10.4239/wjd.v12. i12.2036
  9. Agrawal S, Makuch S, Dróżdż M, Dudzik T, Domański I, Poręba R, et al. The impact of hypoglycemia on patients with diabetes mellitus: a cross-sectional analysis. J Clin Med 2022;11(3):626. doi:10.3390/jcm11030626
  10. Ratzki-Leewing A, Harris SB, Mequanint S, Reichert SM, Belle Brown J, Black JE, et al. Real-world crude incidence of hypoglycemia in adults with diabetes: results of the InHypo-DM Study, Canada. BMJ Open Diabetes Res Care 2018;6(1):e000503. doi:10.1136/bmjdrc-2017-000503
  11. O’Brien BC, Harris IB, Beckman TJ, Reed DA, Cook DA. Standards for reporting qualitative research: a synthesis of recommendations. Acad Med 2014;89(9):1245-51. doi:10.1097/acm.0000000000000388
  12. Quilliam BJ, Simeone JC, Ozbay AB. Risk factors for hypoglycemia-related hospitalization in patients with type 2 diabetes: a nested case-control study. Clin Ther 2011;33(11):1781-91. doi:10.1016/j.clinthera.2011.09.020
  13. Davis TM, Brown SG, Jacobs IG, Bulsara M, Bruce DG, Davis WA. Determinants of severe hypoglycemia complicating type 2 diabetes: the Fremantle diabetes study. J Clin Endocrinol Metab 2010;95(5):2240-7. doi:10.1210/jc.2009-2828
  14. Lontchi-Yimagou E, You JY, Carey M, Gabriely I, Shamoon H, Hawkins M. Potential approaches to prevent hypoglycemia-associated autonomic failure. J Investig Med 2018;66(3):641- 7. doi:10.1136/jim-2017-000582
  15. Stuckey HL, Desai U, King SB, Popadic L, Levinson W, Kirson NY, et al. The experience of a severe hypoglycaemic event from the perspective of people with diabetes and their caregivers: “what am I going to do?”. Diabet Med 2022;39(4):e14745. doi:10.1111/dme.14745
  16. Wyszyńska J, Łuszczki E, Sobek G, Mazur A, Dereń K. Association and risk factors for hypertension and dyslipidemia in young adults from Poland. Int J Environ Res Public Health 2023;20(2):982. doi:10.3390/ijerph20020982
  17. Jaya MK, Rahmawati F, Yasin NM, Ikawati Z. Profile and factors associated with quality of life among outpatients with type 2 diabetes mellitus in Bali, Indonesia. Trop J Pharm Res 2024;23(7):1101-9. doi:http://dx.doi.org/10.4314/tjpr.v23i7.8
  18. Gupta RC, Chang D, Nammi S, Bensoussan A, Bilinski K, Roufogalis BD. Interactions between antidiabetic drugs and herbs: an overview of mechanisms of action and clinical implications. Diabetol Metab Syndr 2017;9:59. doi:10.1186/ s13098-017-0254-9
  19. Jaya MA, Endarti D, Ayu Kartika IG, Veryanti PR, Swastini DA. The role of medication reminder technology as an enhancement of patients compliance. Int J Pharm Res 2020;12(1):418-27. doi:10.31838/ijpr/2020.SP1.052
  20. Kimura Y, Kimura N, Akazawa M. Nutrition-related risk and severe hypoglycemia in older adult outpatients with and without diabetes. Clin Case Rep 2022;10(1):e05317. doi:10.1002/ccr3.5317
  21. Zhang Y, Li S, Zou Y, Wu X, Bi Y, Zhang L, et al. Fear of hypoglycemia in patients with type 1 and 2 diabetes: a systematic review. J Clin Nurs 2021;30(1-2):72-82. doi:10.1111/jocn.15538
  22. Younk LM, Mikeladze M, Tate D, Davis SN. Exercise-related hypoglycemia in diabetes mellitus. Expert Rev Endocrinol Metab 2011;6(1):93-108. doi:10.1586/eem.10.78
  23. Ingrosso DM, Primavera M, Samvelyan S, Tagi VM, Chiarelli F. Stress and diabetes mellitus: pathogenetic mechanisms and clinical outcome. Horm Res Paediatr 2023;96(1):34-43. doi:10.1159/000522431
  24. Alwafi H, Alsharif AA, Wei L, Langan D, Naser AY, Mongkhon P, et al. Incidence and prevalence of hypoglycaemia in type 1 and type 2 diabetes individuals: a systematic review and meta-analysis. Diabetes Res Clin Pract 2020;170:108522. doi:10.1016/j.diabres.2020.108522
  25. Snoek FJ, Jiletcovici A, Bushnell DM, Child CJ, Bajpai SK, Spaepen E, et al. 285-OR: conversations and reactions around severe hypoglycemia (CRASH): US results from a global survey of people with T1DM or insulin-treated T2DM and caregivers. Diabetes 2019;68(Suppl 1):285-OR. doi:10.2337/ db19-285-OR
  26. Frier BM. Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications. Nat Rev Endocrinol 2014;10(12):711- 22. doi:10.1038/nrendo.2014.170
  27. Sun XM, Tan JC, Zhu Y, Lin L. Association between diabetes mellitus and gastroesophageal reflux disease: a meta-analysis. World J Gastroenterol 2015;21(10):3085-92. doi:10.3748/ wjg.v21.i10.3085